Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1977 1
1985 2
1987 1
1989 1
1990 2
1991 3
1993 3
1994 1
1995 2
1996 3
1997 1
1998 3
1999 3
2000 2
2001 5
2002 5
2003 2
2004 2
2005 2
2006 3
2007 8
2008 2
2009 3
2010 6
2011 3
2012 7
2013 2
2014 3
2015 6
2016 8
2017 6
2018 3
2019 6
2020 3
2021 7
2022 6
2023 6

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
Hypertrophic cardiomyopathy: part 1 - introduction, pathology and pathophysiology.
Varma PK, Neema PK. Varma PK, et al. Ann Card Anaesth. 2014 Apr-Jun;17(2):118-24. doi: 10.4103/0971-9784.129841. Ann Card Anaesth. 2014. PMID: 24732610 Free article. Review.
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease with many genotype and phenotype variations. Earlier terminologies, hypertrophic obstructive cardiomyopathy and idiopathic hypertrophic sub-aortic stenosis are n …
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease with many genotype and phenotype variation …
The electrocardiogram in the diagnosis and management of patients with hypertrophic cardiomyopathy.
Finocchiaro G, Sheikh N, Biagini E, Papadakis M, Maurizi N, Sinagra G, Pelliccia A, Rapezzi C, Sharma S, Olivotto I. Finocchiaro G, et al. Heart Rhythm. 2020 Jan;17(1):142-151. doi: 10.1016/j.hrthm.2019.07.019. Epub 2019 Aug 10. Heart Rhythm. 2020. PMID: 31349064 Review.
To date, the ECG remains an irreplaceable first step when evaluating patients with hypertrophic cardiomyopathy (HCM) and an abnormal ECG may be the only manifestation of disease at an early stage. ...
To date, the ECG remains an irreplaceable first step when evaluating patients with hypertrophic cardiomyopathy (HCM) and an ab …
Apical Hypertrophic Cardiomyopathy: The Variant Less Known.
Hughes RK, Knott KD, Malcolmson J, Augusto JB, Mohiddin SA, Kellman P, Moon JC, Captur G. Hughes RK, et al. J Am Heart Assoc. 2020 Mar 3;9(5):e015294. doi: 10.1161/JAHA.119.015294. Epub 2020 Feb 28. J Am Heart Assoc. 2020. PMID: 32106746 Free PMC article. Review. No abstract available.
The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography.
Lancellotti P, Pellikka PA, Budts W, Chaudhry FA, Donal E, Dulgheru R, Edvardsen T, Garbi M, Ha JW, Kane GC, Kreeger J, Mertens L, Pibarot P, Picano E, Ryan T, Tsutsui JM, Varga A. Lancellotti P, et al. Eur Heart J Cardiovasc Imaging. 2016 Nov;17(11):1191-1229. doi: 10.1093/ehjci/jew190. Eur Heart J Cardiovasc Imaging. 2016. PMID: 27880640 Free article. Review.
The genetic basis of hypertrophic cardiomyopathy in cats and humans.
Kittleson MD, Meurs KM, Harris SP. Kittleson MD, et al. J Vet Cardiol. 2015 Dec;17 Suppl 1(Suppl 1):S53-73. doi: 10.1016/j.jvc.2015.03.001. J Vet Cardiol. 2015. PMID: 26776594 Free PMC article. Review.
Mutations in genes that encode for muscle sarcomeric proteins have been identified in humans and two breeds of domestic cats with hypertrophic cardiomyopathy (HCM). This article reviews the history, genetics, and pathogenesis of HCM in the two species in order to gi …
Mutations in genes that encode for muscle sarcomeric proteins have been identified in humans and two breeds of domestic cats with hypertr …
Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions.
Dong T, Alencherry B, Ospina S, Desai MY. Dong T, et al. Drug Des Devel Ther. 2023 Apr 8;17:1097-1106. doi: 10.2147/DDDT.S368590. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 37064432 Free PMC article. Review.
Hypertrophic cardiomyopathy (HCM) is a condition with abnormal hypertrophy of the left ventricle in the absence of common causes. ...
Hypertrophic cardiomyopathy (HCM) is a condition with abnormal hypertrophy of the left ventricle in the absence of common caus …
Thirty-year outcome in children with hypertrophic cardiomyopathy based on the type.
Tsuda E, Ito Y, Kato Y, Sakaguchi H, Ohuchi H, Kurosaki K. Tsuda E, et al. J Cardiol. 2022 Dec;80(6):557-562. doi: 10.1016/j.jjcc.2022.07.016. Epub 2022 Aug 10. J Cardiol. 2022. PMID: 35961804 Review.
BACKGROUND: We reviewed the long-term outcome of children with hypertrophic cardiomyopathy (HCM) based on the type. METHODS: We reviewed the medical records of 100 patients (male 54 female 46) with HCM at our hospital between 1977 and 2015. ...RESULTS: The age at th …
BACKGROUND: We reviewed the long-term outcome of children with hypertrophic cardiomyopathy (HCM) based on the type. METHODS: W …
Long-term outcome of nonobstructive versus obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis.
Pelliccia F, Pasceri V, Limongelli G, Autore C, Basso C, Corrado D, Imazio M, Rapezzi C, Sinagra G, Mercuro G; Working Group on Cardiomyopathies and Pericardial Diseases of the Italian Society of Cardiology. Pelliccia F, et al. Int J Cardiol. 2017 Sep 15;243:379-384. doi: 10.1016/j.ijcard.2017.06.071. Int J Cardiol. 2017. PMID: 28747036 Review.
BACKGROUND: Prognosis of hypertrophic cardiomyopathy (HCM) is particularly heterogeneous. Patients with nonobstructive HCM (NOCM) are thought to be at relatively low-risk as compared with obstructive HCM (HOCM) with no need of major treatment options. ...Aim of this …
BACKGROUND: Prognosis of hypertrophic cardiomyopathy (HCM) is particularly heterogeneous. Patients with nonobstructive HCM (NO …
Hereditary myosin myopathies.
Oldfors A. Oldfors A. Neuromuscul Disord. 2007 May;17(5):355-67. doi: 10.1016/j.nmd.2007.02.008. Epub 2007 Apr 16. Neuromuscul Disord. 2007. PMID: 17434305 Review.
The majority of more than 200 dominant missense mutations in MYH7 are associated with hypertrophic/dilated cardiomyopathy without signs or symptoms of skeletal myopathy. Several mutations in two different parts of the slow/beta-cardiac MyHC rod region are associated …
The majority of more than 200 dominant missense mutations in MYH7 are associated with hypertrophic/dilated cardiomyopathy with …
Hypertrophic cardiomyopathy part II--anesthetic and surgical considerations.
Varma PK, Raman SP, Neema PK. Varma PK, et al. Ann Card Anaesth. 2014 Jul-Sep;17(3):211-21. doi: 10.4103/0971-9784.135852. Ann Card Anaesth. 2014. PMID: 24994732 Free article. Review.
Hypertrophic cardiomyopathy (HCM) poses many unique challenges regarding the conduct of anesthesia and surgery. ...
Hypertrophic cardiomyopathy (HCM) poses many unique challenges regarding the conduct of anesthesia and surgery. ...
126 results